General Biotechnologies careers

General Biotechnologies identifies and develops undervalued discoveries in the life sciences. Our flagship program — Nivien Therapeutics — is a venture-backed oncology platform.

We plan to make Nivien Therapeutics the first of several successful translations from undeveloped scientific research to real-world therapeutics. Our model extends beyond healthcare. Biotechnology is advancing quickly, but rapid growth means that promising discoveries will be overlooked. We will work with scientists and tech transfer offices in Massachusetts and beyond to realize the full potential of innovation in this sector.